GT Biopharma, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
GT Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • GT Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -123 %, a 115% decline year-over-year.
  • GT Biopharma, Inc. annual Return On Assets for 2023 was -44.4 %, a 52.5% increase from 2022.
  • GT Biopharma, Inc. annual Return On Assets for 2022 was -93.4 %.
  • GT Biopharma, Inc. annual Return On Assets for 2020 was -1.43K %, a 381% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -123 -65.9 -115% Jul 1, 2024 Sep 30, 2024
Q2 2024 -91.9 -14.6 -18.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -66.1 +10.3 +13.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -44.4 +49.1 +52.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -57.5 +69.6 +54.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -77.3 Apr 1, 2023 Jun 30, 2023
Q1 2023 -76.4 Jan 1, 2023 Mar 31, 2023
Q4 2022 -93.4 Oct 1, 2022 Dec 31, 2022
Q3 2022 -127 Jul 1, 2022 Sep 30, 2022
Q4 2020 -1.43K -1.13K -381% Oct 1, 2020 Dec 31, 2020
Q3 2020 -3.52K -3.3K -1537% Jul 1, 2020 Sep 30, 2020
Q2 2020 -9.03K -8.07K -842% Apr 1, 2020 Jun 30, 2020
Q1 2020 -533 -228 -74.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -297 -113 -61.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -215 -83.2 -63.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -959 -898 -1474% Apr 1, 2019 Jun 30, 2019
Q1 2019 -305 -227 -293% Jan 1, 2019 Mar 31, 2019
Q4 2018 -184 -70.9 -62.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -132 +88 +40.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -60.9 +12K +99.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -77.7 +5K +98.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -113 -6.8K -102% Oct 1, 2017 Dec 31, 2017
Q3 2017 -220 +8.6K +97.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -12K -2.8K -30.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -5.08K -25.3K -125% Jan 1, 2017 Mar 31, 2017
Q4 2016 6.69K +11.9K Oct 1, 2016 Dec 31, 2016
Q3 2016 -8.82K -6.58K -293% Jul 1, 2016 Sep 30, 2016
Q2 2016 -9.23K -7.13K -341% Apr 1, 2016 Jun 30, 2016
Q1 2016 20.2K +25.9K Jan 1, 2016 Mar 31, 2016
Q4 2015 -5.17K +188 +3.52% Oct 1, 2015 Dec 31, 2015
Q3 2015 -2.24K -194 -9.46% Jul 1, 2015 Sep 30, 2015
Q2 2015 -2.09K -684 -48.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -5.68K -4.53K -393% Jan 1, 2015 Mar 31, 2015
Q4 2014 -5.36K -4.94K -1186% Oct 1, 2014 Dec 31, 2014
Q3 2014 -2.05K -1.38K -208% Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.41K -36.5 -2.66% Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.15K +1.79K +60.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -417 +3K +87.8% Oct 1, 2013 Dec 31, 2013
Q3 2013 -665 +3.7K +84.8% Jul 1, 2013 Sep 30, 2013
Q2 2013 -1.37K +713 +34.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -2.94K -1.87K -174% Jan 1, 2013 Mar 31, 2013
Q4 2012 -3.42K Oct 1, 2012 Dec 31, 2012
Q3 2012 -4.37K Jul 1, 2012 Sep 30, 2012
Q2 2012 -2.09K Apr 1, 2012 Jun 30, 2012
Q1 2012 -1.07K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.